Jodie Sherman Gillon

Jodie Sherman Gillon has over 20 years of experience in various roles in the healthcare industry. Jodie is currently the President & Chief Executive Officer at BioCT since May 2023. Prior to this, they served as the SVP Corporate Affairs & Patient Advocacy at Peptilogics from July 2021 to May 2023. Before that, they held positions at Abeona Therapeutics, serving as the Chief Patient Officer & Head of Clinical Affairs from January 2021 to July 2021, and as the VP, Patient Advocacy & Clinical Affairs from June 2019 to January 2021. Jodie also worked at Pfizer as the Global Medical Lead, Patient Engagement Rare Diseases from January 2018 to April 2019. Other notable roles include Head, Patient Advocacy & Professional Affairs; Global Medical Affairs at Achillion Pharmaceuticals, Inc., Head, External Interface Office/Chief Medical Office at AstraZeneca, and Director, Publications Management Team at Pfizer. Jodie started their career at CDC (Tel Aviv branch) as a Health Economist in 1999 before moving on to Oridion Medical as a Health Economist & Director, Medical Education from 2000 to 2002. Jodie then joined Novartis as a Global Communications Lead from 2002 to 2006.

Jodie Sherman Gillon completed their high school education at Stuyvesant from 1989 to 1993, focusing on a general high school curriculum. Following their high school education, they enrolled in Georgetown University from 1993 to 1997 and earned a BSFS degree in International Health. Subsequently, they pursued further education at The Hebrew University of Jerusalem from 1998 to 2000, where they obtained an MPH degree specializing in EPI/HEOR. Later, Jodie returned to Georgetown University, though the exact years are not specified, and completed additional coursework in International Health and Business Diplomacy. Lastly, Jodie attended the Massachusetts Institute of Technology's Executive Leadership Program in 2015, which emphasized Business Administration and Management, General.